Immune Response to Ovarian and other gynaecological Cancers (IROC) Biobank, Canada

Registration Status: Completed

Objective: Immune Response to Ovarian and other gynecological Cancers (IROC) biobank is leading to a better understanding of the immune response to ovarian cancer and other gynecological cancers. The findings from this study are helping us design new immune-based treatments for these diseases.

Registered Biobank Name Immune Response to Ovarian and other gynaecological Cancers (IROC) Biobank
Biobank Leader David Bond
Country Canada
Email for biobank inquiries
Principal Investigator Brad Nelson
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Oligo - Collection aimed at supporting several research projects, a research group or a research consortium
Biospecimen Collected: